ARTICLE | Emerging Company Profile
How to train your dragon: Welsh spinout Draig draws $140M for CNS programs
SV Health, others back programs from Cardiff University in nine-digit series A
June 20, 2025 8:57 PM UTC
A group of pharma veterans who returned to academia has joined forces with venture firm SV Health to create Draig, a well-funded start-up targeting CNS disorders with precision-tuned molecules.
Draig Therapeutics Ltd. emerged from stealth mode on Thursday with a portfolio of molecules targeting AMPA and GABA A receptors that are designed to address unmet needs among neuropsychiatry indications. The programs emerged from the Medicines Discovery Institute (MDI) at Cardiff University in Wales...